Delivery Order SPE2DB22D3016-SPE2DB25FBCZ4
- Not listed
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $188,370 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply Emgality 120 mg/ml pen injectors. The contract has a period of performance of July 12-13, 2023, with place of performance in Conshohocken, Pennsylvania. No subcontractors or additional context were provided regarding the Defense Logistics Agency's programs or this particular requirement. The...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 29, 2025, for Emgality 120 mg/ml pen injectors valued at $1,037.40. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of July 30, 2025. The order is being funded by the Defense Logistics Agency's Medical Supply Chain and will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,309.37 to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/ml pen injectors. This firm fixed price, competitively awarded contract was issued on August 5, 2025, with an ultimate completion date of August 6, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $3,034.80 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors. This firm fixed-price, competitively awarded contract was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. No set-aside designation was applied to this award. This...
- The Defense Logistics Agency awarded a $1,729.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors, with an ultimate completion date of July 25, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, was awarded a $278.20 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to supply 4561358048 units of Emgality 120 mg/ml pen injectors. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance from June 28, 2023 through June 29, 2023. No subcontractors or set aside designations were identified. DLA...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $834.54 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply Emgality 120 mg/ml pen injectors. The contract has a period of performance from August 7-8, 2023. Place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this delivery order is associated...
- The Defense Logistics Agency awarded a delivery order valued at $1,213.80 to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors, with an ultimate completion date of July 29, 2025. The contract, issued on July 28, 2025, employs firm fixed-price pricing and was awarded through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,990.63 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as the...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $548 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply Emgality 120 mg/ml pen injectors. The contract has a period of performance of one day, from August 30th to August 31st, 2023. Place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were indicated. This order is likely associated...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBCZ4Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has received a delivery order from the Defense Logistics Agency (DLA) valued at $7,827.19 for Emgality 120 mg/ml pen injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 25, 2025, and represents a non-set-aside contract. The product will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle running through December 2026. Emgality is a CGRP receptor antagonist indicated for migraine prevention and reflects the company's established role as a primary pharmaceutical distributor for federal military and veteran healthcare systems. As a major pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other government entities, AmerisourceBergen Drug Corp leverages this prime IDC to supply an extensive portfolio of brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 7/24/25 |